Loading…
Maxpharma (მაქსფარმა) — a small Georgian pharmaceutical company (revenue ~GEL 2–3m, thin gross margin ~9–12%, asset-light) classified as wholesale/distribution by inference; no financial filings after FY2020, so likely dormant. No public presence.
| Line item | 2018 | 2019 | 2020 | CAGR |
|---|---|---|---|---|
| 3,225 | 2,563 | 1,840 | -24.5% | |
| Total COGS | 2,933 | 2,327 | 1,618 | -25.7% |
| Gross Profit | 292 | 236 | 222 | -12.8% |
| Gross Margin | 9.0% | 9.2% | 12.1% | |
| 335 | 316 | 283 | -8.1% | |
| EBITDA | 43 | 80 | 61 | +19.2% |
| EBITDA Margin | 1.3% | 3.1% | 3.3% | |
| Total D&A | 8 | 7 | 6 | -9.3% |
| EBIT / Operating Income | 50 | 87 | 67 | +15.4% |
| Profit Before Tax | 50 | 87 | 67 | +15.4% |
| Total Income Tax | 0 | 0 | 0 | |
| Net Profit / (Loss) | 50 | 87 | 67 | +15.4% |
| Net Margin | 1.6% | 3.4% | 3.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.